Reporting person on SEC Form 4

Ian Mortimer

Ian Mortimer is PRESIDENT & CEO at Xenon Pharmaceuticals. OQRO lists 1 transaction filed with the SEC under this name, the latest on Oct 1, 2026, each linked to the official Form 4.

PRESIDENT & CEO

Disclosures on record

1

Companies involved

1

Disclosure history

Xenon PharmaceuticalsXENE
Sep 30, 2026Bought~$1.12Mdisclosed Oct 1
Details Official record